Atlas Trials

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

Clinical trial NCT02370784 · COMPLETED

Trial details

NCT number
NCT02370784
Sponsor
Robyn T. Domsic, MD, MPH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Scleroderma
Start date
2015-02-01
Primary completion
2018-12-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.